FOUNDERS GROVE WEALTH PARTNERS, LLC

Position in MRK — Merck & Co., Inc.

CIK 2046157 RICHMOND, VA

Position in MRK

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$637,488

+$119,159 QoQ

Shares Held

4,961

+15.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#2,487

of 3,769 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FOUNDERS GROVE WEALTH PARTNERS, LLC holds $22,439,048 across 6 Drug Manufacturers - General names. MRK ranks #4 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	15,366	$18,430,442
2	JNJ	Johnson & Johnson	8,327	$2,114,808
3	ABBV	AbbVie Inc.	2,939	$739,569
4	MRK	Merck & Co., Inc. This page	4,961	$637,488
5	GILD	Gilead Sciences, Inc.	2,346	$296,393
6	NVS	Novartis AG	1,406	$220,348

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$637,488	4,961	+15.1%	Shares	Sole	2026-07-22
2026-03-31	$518,329	4,309	+4.8%	Shares	Sole	2026-04-15
2025-12-31	$432,829	4,112	+14.9%	Shares	Sole	2026-01-12
2025-09-30	$300,385	3,579	+12.2%	Shares	Sole	2025-10-17
2025-06-30	$252,599	3,191	-5.2%	Shares	Sole	2025-07-28
2025-03-31	$302,132	3,366	+2.4%	Shares	Sole	2025-04-16
2024-12-31	$326,990	3,287	—	Shares	Sole	2025-01-14
No filing history on record for this holder in this stock.